GlassScriptPhysician profile
Marc William Fromer
NPI 1063828077
$9,355.21
in general payments reported to CMS, 2019-2025
20 companies · $1,682 in 2025
The $1,682 reported for 2025 was more than what 78% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $125 · 2021: $197 · 2022: $1,013 · 2023: $1,816 · 2024: $4,273 · 2025: $1,682.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,513 · Travel and Lodging: $2,233 · Gift: $24.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,512.59 |
| Travel and Lodging | $2,233.48 |
| Gift | $24.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,395.36 | 2023-2025 | Da Vinci Surgical System |
| Davol INC. | $2,018.06 | 2019-2025 | Phasix Mesh, Arista Ah Flexitip, Arista |
| Integra Lifesciences Corporation | $1,215.74 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Histosonics, INC. | $1,099.62 | 2024 | |
| Musculoskeletal Transplant Foundation INC. | $477.08 | 2024-2025 | |
| Sanara Medtech INC. | $382.03 | 2024-2025 | Biasurge, Celleraterx |
| Becton, Dickinson and Company | $270.07 | 2022-2024 | Phasix Mesh |
| Pacira Pharmaceuticals Incorporated | $240.32 | 2020-2021 | |
| Convatec INC. | $180.18 | 2025 | |
| Acera Surgical, INC. | $151.70 | 2025 | Restrata Wound Matrix |
| Biotissue Holdings INC. | $147.95 | 2023 | |
| Dilon Technologies, INC. | $141.97 | 2024 | Hemoblast Bellows |
| Hologic Sales and Service, LLC | $126.38 | 2023-2025 | Coolseal Generator |
| Abbvie INC. | $120.58 | 2022 | |
| Ambu INC. | $115.48 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $112.20 | 2019 | |
| Innocoll Pharmaceuticals Limited | $59.21 | 2022 | |
| Kerecis Limited | $51.29 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Lexington Medical, INC. | $26.29 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Pfizer INC. | $23.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Fromer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.